12:00 AM
 | 
Sep 15, 2008
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Genzyme sales and marketing update

According to FDA, Genzyme recalled one lot of Thymoglobulin after the rabbit anti-thymocyte immunoglobulin failed a stability test based upon an opalescence...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >